엑소좀 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Exosomes Market is presumed to reach the market size of nearly USD 224.98 Million by 2032 from USD 169.74 Million in 2023 with a CAGR of 3.18% under the study period 2024-2032.

Exosomes refer to an extracellular vesicle that contains protein, RNA, and DNA of the cells that produce them. Exosome therapy is the new treatment used in the early stage of cancer detection. Exosomes extracted from cow milk are majorly used to deliver therapeutic molecules against breast and lung cancers. Exosomes have huge potential to act like vehicles for drug delivery because they have natural material transportation properties such as high biocompatibility and intrinsic long-term circulation. Intercellular communication through exosomes supposed to be involved in the pathogenesis of a variety of disorders such as cancer, inflammatory and neurodegeneration diseases.

MARKET DYNAMICS

The rising prevalence of cancer cases across the globe, along with technological advancements in exosomes isolation and analytical procedures, are the major factors driving the exosomes market over the forecast period. Moreover, increasing advanced applications of exosomes in therapeutic and the rising emphasis on early diagnosis of cancer are highly contributing to the growth of the global exosomes market. The rising healthcare expenditure and growing awareness related to healthcare creates a positive impact on the growth of the exosomes market globally. Furthermore, increasing research and development in oncology by private and public institutions, coupled with strong pipeline products of key players, are expected to create a lucrative opportunity for the market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Exosomes. The growth and trends of Exosomes industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Exosomes market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Kits & Reagents
• Instruments
• Services

By Workflow

• Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others)
• Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others)

By Application

• Cancer
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Others

By End-Use

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostics Centers
• Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Exosomes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Exosomes market include Danaher Corporation, Hologic Inc., Fujifilm Holdings Corporation, Lonza, Miltenyi Biotec, Bio-Techne Corporation, QIAGEN, Thermo Fisher Scientific Inc., Abcam Plc, RoosterBio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. EXOSOMES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Workflow
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-Use
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EXOSOMES MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product
• 5.4. Kits & Reagents Historic and Forecast Sales By Regions
• 5.5. Instruments Historic and Forecast Sales By Regions
• 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL EXOSOMES MARKET ANALYSIS BY WORKFLOW

• 6.1. Overview By Workflow
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Workflow
• 6.4. Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Historic and Forecast Sales By Regions
• 6.5. Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Historic and Forecast Sales By Regions

7. GLOBAL EXOSOMES MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Application
• 7.4. Cancer Historic and Forecast Sales By Regions
• 7.5. Neurodegenerative Diseases Historic and Forecast Sales By Regions
• 7.6. Cardiovascular Diseases Historic and Forecast Sales By Regions
• 7.7. Infectious Diseases Historic and Forecast Sales By Regions
• 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL EXOSOMES MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-Use
• 8.2. Historical and Forecast Data
• 8.3. Analysis By End-Use
• 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
• 8.5. Hospitals & Diagnostics Centers Historic and Forecast Sales By Regions
• 8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL EXOSOMES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EXOSOMES COMPANIES

• 10.1. Exosomes Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF EXOSOMES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Danaher Corporation
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Hologic Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Fujifilm Holdings Corporation
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Lonza
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Miltenyi Biotec
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Bio-Techne Corporation
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. QIAGEN
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Thermo Fisher Scientific Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Abcam Plc
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. RoosterBio Inc
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies